Author Claim Review

 Quick Explanation Copied

 Long Explanation

Career Impact and Bibliometrics

OpenAlex records 188 works with 25,676 citations and an h-index of 65 for Fen-Biao Gao (ORCID 0000-0001-8873-5404), with citations rising steeply after 2012 and peaking above 2,100/year (2020-2021), indicating sustained field-wide influence in neuroscience, cell biology, and genetics OpenAlex bibliometric profile. His three most-cited works are co-authored autophagy guidelines (2012: 3,999; 2016: 5,894 citations), and landmark mechanistic papers include the C9ORF72 nucleocytoplasmic transport study in Nature (841 citations) and stress-granule interactome work in Cell (915 citations) Nature C9ORF72 transport paper Cell stress granule interactome paper. Career longevity is notable: first-author developmental work spans Drosophila dendritogenesis and oligodendrocyte timing since the 1990s Drosophila dendrite development paper EMBO oligodendrocyte p27 paper.

Recent Scientific Strength

Three evaluated recent papers score 8 for scientific quality and 7-9 for novelty. The 2026 CYLD work links gain-of-function M719V-CYLD to bvFTD-like behaviors and mPFC layer-5 pyramidal neuron hypoexcitability via Akt-mTOR-autophagy dysregulation, with adequate per-condition electrophysiology sample sizes (n=12-19 cells/group) and both sexes included, though it relies on ~3-fold AAV overexpression and shows no TDP-43 pathology or neurodegeneration CYLD M719V FTD mouse model preprint. The 2023 eLife paper maps canonical AUG initiation codons for antisense poly-PR/poly-PG translation in C9ORF72 ALS/FTD, showing EIF2D is dispensable for antisense DPR synthesis, but with only a few patient iPSC lines and overexpression plasmids eLife C9ORF72 DPR translation paper. The 2017 cathepsin L work identifies the first lysosomal intracellular PGRN protease with detailed LC-MS/MS cleavage mapping, yet validation rests on overexpression systems and a single postmortem FTLD brain, with no Cat L knockout animal data Cathepsin L progranulin protease paper. A 2016 EMBO Journal commentary on the C9ORF72-WDR41-SMCR8 RAB GEF complex reflects his group's leadership in defining C9ORF72's normal function EMBO C9ORF72 autophagy complex paper.

Critical Assessment

Strengths: mechanistic depth across molecular, cellular, synaptic, circuit, and behavioral levels; multi-model approaches (mouse AAV, iPSC neurons, cell lines, Drosophila); consistent NIH funding (R37NS057553, R35NS097273, etc.); transparent limitation reporting and declared conflicts; leadership in defining central ALS/FTD mechanisms (C9ORF72 DPR translation, autophagy, progranulin lysosomal biology). Weaknesses/blindspots: recurring dependence on overexpression constructs across the CYLD, DPR, and cathepsin L papers, which may not recapitulate endogenous regulation; small patient-derived iPSC line numbers; limited in vivo validation (single postmortem brain in the cathepsin L study); translational gaps (absence of hallmark FTD pathology in the CYLD model). No evidence of fabricated data, undisclosed industry influence, or p-hacking was found in these records, though Biogen affiliations appear in one co-author list (declared). What would change this assessment: failure of independent labs to replicate the CYLD-M719V behavioral phenotype, or demonstration that cathepsin L does not process PGRN in intact brain, would materially weaken recent claims.

 BGPT Author Review

Scientific Quality

h-index 65, ~25.7k citations, and co-authorship on field-defining Nature/Cell papers plus autophagy guidelines reflect elite scientific standing. Recent first/corresponding-author work is mechanistically deep and well-controlled. Main deductions: repeated reliance on overexpression systems and limited in vivo validation of key protease and start-codon claims; no detected data-integrity red flags.

Communication Quality

Papers are clearly structured with explicit problem statements, falsification criteria, methods detail, and software/tool reporting. Accessibility to non-specialists is moderate given dense cell/molecular terminology; recent work lacks notable lay summaries.

Author Novelty

Consistently high novelty scores (7-9): first identification of cathepsin L as a lysosomal PGRN protease, novel AUG-dependent antisense DPR translation mechanisms, and a first-in-field CYLD-M719V circuit-level FTD model. Not paradigm-breaking, but consistently first-mover on central ALS/FTD mechanisms.

Scientific Rigor

Adequate sample sizes for electrophysiology (n=12-19 cells/group), both sexes included, orthogonal methods (LC-MS/MS, electrophysiology, CRISPR, iPSC neurons), transparent limitation sections, and declared conflicts. Deductions: overexpression dependence across multiple papers, single-patient tissue validation, small iPSC line numbers, and limited in vivo rescue/causality experiments.